Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Oct 15;15(20):5557-66.

The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex

Affiliations

The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex

T Aso et al. EMBO J. .

Abstract

The elongin (SIII) complex strongly stimulates the rate of elongation by RNA polymerase II by suppressing transient pausing by polymerase at many sites along the DNA. Elongin (SIII) is composed of a transcriptionally active A subunit and two small regulatory B and C subunits, which bind stably to each other to form a binary complex that interacts with elongin A and strongly induces its transcriptional activity. The elongin (SIII) complex is a potential target for negative regulation by the von Hippel-Lindau (VHL) tumor suppressor protein, which is capable of binding stably to the elongin BC complex and preventing it from activating elongin A. Here, we identify an elongin A domain sufficient for activation of elongation and demonstrate that it is a novel type of inducible activator that targets the RNA polymerase II elongation complex and is evolutionarily conserved in species as distantly related as Caenorhabditis elegans and man. In addition, we demonstrate that both the elongin A elongation activation domain and the VHL tumor suppressor protein interact with the elongin BC complex through a conserved elongin BC binding site motif that is essential for induction of elongin A activity by elongin BC and for tumor suppression by the VHL protein.

PubMed Disclaimer

References

    1. Biochemistry. 1974 Jan 15;13(2):211-22 - PubMed
    1. J Biol Chem. 1992 Feb 25;267(6):3795-800 - PubMed
    1. J Biol Chem. 1982 May 10;257(9):5286-95 - PubMed
    1. EMBO J. 1982;1(8):945-51 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources